Try our beta test site

Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Kerem Eithan, Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00889434
First received: April 20, 2009
Last updated: February 22, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 16, 2015
  Primary Completion Date: April 16, 2015 (Final data collection date for primary outcome measure)